Publications

See a complete PubMed list of publications by Mark Pimentel, MD.

Selected Key Publications

Fodor AA, Pimentel M, Chey WD, Lembo A, Golden PL, Israel RJ, Carroll IM. Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome [published online ahead of print April 30, 2018]. Gut Microbes. 2018 Apr 30:1-28. https://www.tandfonline.com/doi/full/10.1080/19490976.2018.1460013.

Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M. Assessment of anti-vinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome. Dig Dis Sci. 2017 Jun;62(6):1480-1485. https://link.springer.com/article/10.1007%2Fs10620-017-4585-z.

Kramer-Sarrett M, Lin E, Chua KS, Pichetshote N, Rezaie A, Pimentel M. Examination of the effects of breath hydrogen and methane levels on the EC/IRII. Can Soc Forensic Sci J. 2017 May 5;50(3):125-130. http://www.tandfonline.com/doi/full/10.1080/00085030.2017.1313474.

Sung J, Morales W, Kim G, Pokkunuri V, Weitsman S, Rooks E, Marsh Z, Barlow GM, Chang C, Pimentel M. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post-infectious functional and microbial bowel changes. Neurogastroenterol Motil. 2013 Jun;25(6):529-537. http://onlinelibrary.wiley.com/doi/10.1111/nmo.12118/full.

Pimentel M, Morales W, Rezaie A, Marsh E, Lembo A, Mirocha J, Leffler DA, Marsh Z, Weitsman S, Chua KS, et al. Development and validation of a biomarker for diarrhea predominant irritable bowel syndrome in human subjects. Plos One. 2015 May 12;10(5):e0126438. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126438.

Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, et al. Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following Campylobacter jejuni infection in a rat model. Dig Dis Sci. 2014 Nov 26. [Epub ahead of print] http://link.springer.com/article/10.1007%2Fs10620-014-3435-5.

Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Dig Dis Sci. 2014 Jun;59(6):1278-1285. http://link.springer.com/article/10.1007%2Fs10620-014-3157-8.

Triantafyllou K, Chang C, Pimentel M. Methanogens, methane and gastrointestinal motility. J Neurogastroenterol Motil. 2014 Jan;20(1):31-40. http://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm.2014.20.1.31.

Mathur R, Kim G, Morales W, Sung J, Rooks E, Pokkunuri V, Weitsman S, Barlow GM, Chang C, Pimentel M. Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats. Obesity (Silver Spring). 2013 Apr;21(4):748-754. http://onlinelibrary.wiley.com/doi/10.1002/oby.20277/abstract.

Sung J, Morales W, Kim G, Pokkunuri V, Weitsman S, Rooks E, Marsh Z, Barlow GM, Chang C, Pimentel M. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes. Neurogastroenterol Motil. 2013 Jun;25(6):529-537. http://onlinelibrary.wiley.com/doi/10.1111/nmo.12118/abstract.

Pokkunuri V, Pimentel M, Morales W, Jee SR, Alpern J, Weitsman S, Marsh Z, Low K, Hwang L, Khoshini R, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motil. 2012 Oct;18(4):434-442. http://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm.2012.18.4.434.

Basseri R, Basseri B, Pimentel M, Chong K, Youdim A, Low K, Hwang L, Soffer E, Chang C, Mathur R. Intestinal methane production in obese individuals is associated with a higher body mass index. Gastro and Hep. 2012;8(1):22-28. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277195/.

Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of small intestinal bacterial overgrowth by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012;57(5):1321-1329. http://link.springer.com/article/10.1007%2Fs10620-012-2033-7.

Shah E, Riddle MS, Chang C, Pimentel M. Estimating the contribution of acute gastroenteritis to the overall prevalence of IBS. J Neurogastroenterol Motil. 2012; 18: 200-204. http://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm.2012.18.2.200.

Kim G, Deepinder F, Morales W, Hwang L, Weitsman S, Chang C, Gunsalus R, Pimentel M. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci. May 2012 Dec;57(12):3213-3218. http://link.springer.com/article/10.1007%2Fs10620-012-2197-1.